-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II

Symposia: Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Alexandra Forman, BSc1*, Laura Dodge, ScD2*, Thita Chiasakul, MD3*, Sirui Ma, MD4, Jeffrey I. Zwicker, MD5,6, Ellen McCarthy, PhD, MPH2* and Rushad Patell, MD7

1Harvard Medical School, Cambridge, MA
2Beth Israel Deaconess Medical Center, Boston, MA
3Center of Excellence in Translational Hematology, Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand
4Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA
5Weill Cornell Medical College, New York, NY
6Memorial Sloan Kettering Cancer Center, New York, NY
7Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA

Stefan W Eber, MD1, Andreas Glenthøj, MD, PhD2*, Bertil Glader, MD, PhD3, Dagmar Pospisilova, MD, PhD4*, Eduard J. van Beers, MD, PhD5, Rachael F. Grace, MD, MMSc6, Joan-Lluis Vives Corrons, MD, PhD7*, Hitoshi Kanno, MD, PhD8*, Kevin H.M. Kuo, MD, MSc, FRCPC9, Paola Bianchi, PhD, BSc10, Audra Boscoe, PhD11*, Bryan McGee, PharmD, MBA11*, Yan Yan, MS11*, Junlong Li, PhD11*, Janet H. Ford, MPH, PhD11* and Carl Lander, RN12*

1Special Practice for Pediatric Hematology/Oncology and Children`s Hospital, Technical University, Munich, Germany
2Danish Red Blood Cell Center, Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
3Division of Pediatric Hematology/Oncology, Stanford University School of Medicine, Palo Alto, CA
4Department of Pediatrics, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic
5Center for Benign Hematology, Thrombosis and Hemostasis - Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
6Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA
7Red Blood Cell and Haematopoietic Disorders Research Unit, Institute for Leukaemia Research Josep Carreras, Barcelona, Spain
8Department of Transfusion Medicine and Cell Processing, Tokyo Women's Medical University, Tokyo, JPN
9Division of Hematology, University of Toronto, Toronto, ON, Canada
10Hematology Unit, Pathophysiology of Anemias Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy
11Agios Pharmaceuticals, Inc., Cambridge, MA
12Thrive with PK Deficiency, Minneapolis, MN

Marie-Claude Pelland-Marcotte, MD, PhD1, Alexandra Larouche, MD1*, Valerie Dollo, MD1*, Gabriel Mercier, MD1*, Mahukpe Narcisse U. Singbo, MSc2*, Chantal Ethier, PhD2* and Marie-Christine Boulanger, PhD1*

1CHU de Québec - Université Laval, Québec, QC, Canada
2Centre de Recherche du CHU de Québec, Québec, QC, Canada

Susan Lattimore, BSN1*, Eleanor Carrick, MS1*, Heather MacFarlane, BA1*, Virginie Sirianna, MHA2* and Nicole Crook, RN3*

1The Hemostasis & Thrombosis Center, Oregon Health & Science University, Portland, OR
2UNC Hemophilia & Thrombosis Center, University of North Carolina School of Medicine, Chapel Hill, NC
3Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders, Orange, CA

Amy D. Shapiro, MD1, Robert Schuldt, PhD2*, Zhiyu Xia, PhD2*, Carmen Ng, PhD2*, Lucy Lee, PharmD, MPH2*, Juliana M.L. Biondo, MD2 and Janet S Lee2*

1Indiana Hemophilia & Thrombosis Center, Indianapolis, IN
2Genentech, Inc., South San Francisco, CA

Srikanth Nagalla, MBBS1, Moshe Y. Levy, MD2*, Shruti Chaturvedi, MBBS3, Scott Kolodny, MD4*, Abiola Oladapo5*, Chelsea Bernheisel4*, Elyse Swallow6*, Debbie Goldschmidt, PhD7*, Ali Greatsinger7*, Kirthana Sarathy7*, Loren Ormenaj7* and Michael Vredenburg, PhD4*

1Miami Cancer Institute, Miami, FL
2Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX
3Division of Hematology, Department of Medicine, Johns Hopkins Hospital, BALTIMORE, MD
4Sobi, Inc., Durham, NC
5Sobi Inc., Waltham, MA
6Analysis Group, Inc., Boston, MA
7Analysis Group, Inc., New York, NY

Fartoon M Siad, MD, MSc1, Andrea Lausman, MD2*, Carolyn Snider, MD3*, Martina Trinkaus, MD4*, Filomena Meffe, MD, MSc2* and Michelle Sholzberg, MD, M.Sc5

1Department of Medicine, University of Toronto, Toronto, ON, Canada
2Department of Obstetrics and Gynecology, University of Toronto, Toronto, Canada
3Department of Emergency Medicine, University of Toronto, Toronto, Canada
4Deparment of Medicine, University of Toronto, Toronto, ON, CAN
5Departments of Medicine, and Laboratory Medicine and Pathobiology, St. Michael’s Hospital, Li Ka Shing Knowledge Institute, University of Toronto, Toronto, ON, Canada

Christopher P Keuker, MD1*, Daniel A. Mazzolenis, MD, MBA2 and Ana Baptista, MD3*

1Medical and Scientific Management, Syneos Health, Morrisville, NC
2Syneos Health, Morrisville, NC
3Syneos Health, Lisbon, Portugal

Qiusha Huang, MD1*, Xiaolu Zhu1*, Yun He2*, HaiXia Fu, MD1*, Qi Chen3*, Peng Zhao1*, Jin Wu, MD4*, YingJun Chang, MD, PhD5*, LanPing Xu, MD6*, Xue Xu7*, Xiaohong Zhang8*, Jianliu Wang8*, Xiaojun Huang9* and Xiaohui Zhang, MD10,11

1Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
2Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China
3Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China
4Peking University People's Hospital, Beijing, CHN
5Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China
6Peking University People’s Hospital,Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China
7Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China, Beijing, China
8Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China
9Peking University People's Hospital & Peking University Institute of Hematology,, Beijing, CHN
10Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
11Peking University People's Hospital, Beijing, China

Karlyn A. Martin, MD, MS1, Andrew Sparks, MS2*, Katherine Wilkinson, MS3*, Ryan Packer4*, Deirdra R Terrell, PhD5, Mansour Gergi, MD6, Augusto Ferraris, MD MPH7*, William A. Wood, MD, MPH8, Allen B Repp, MD MSc9*, Nicholas S Roetker, PHD MS10* and Neil Zakai6

1Division of Hematology and Oncology, University of Vermont Larner College of Medicine, Burlington, VT
2Biomedical Statistics Research Core at the University of Vermont, Burlington, VT
3University of Vermont Larner College of Medicine, Burlington, VT
4Biostatistics Core, Laboratory for Clinical Biochemistry Research, University of Vermont Larner College of Medicine, Burlington, VT
5University of Oklahoma Health Sciences Ctr, Oklahoma City, OK
6Larner College of Medicine at the University of Vermont, Burlington, VT
7University of Washington, Ciudad Autonoma De Buenos Aires, BA, ARG
8Division of Hematology/Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
9University of Vermont, Burlington, VT
10Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, MN

Caroline Piatek, MD1, Louis A Jackson III, PharmD2*, Caroline Brethenoux3*, Alyssa DeLuca3*, Zia Choudhry, MD, PhD, MBA4*, Jacqueline Pesa, MSEd, PhD, MPH4*, Alex Lorenzo, BBA3*, Patrick Furey, MS3*, Laura Gonzalez Quijano3*, Rosario Alvarez3*, Julija Paskevicius3* and Nora Sandorfi, MD5*

1Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, USC Norris Comprehensive Cancer Center, Los Angeles, CA
2Janssen Scientific Affairs, LLC, Horsham, PA
3Human Dot Plus, Dallas, TX
4Janssen Scientific Affairs, LLC, Titusville, NJ
5Division of Rheumatology, University of Pennsylvania, Philadelphia, PA

David Araten, MD1, Austin G. Kulasekararaj, MD, MBBS, FRCPath, MRCP2, Jun-ichi Nishimura, MD, PhD3, Regis Peffault De Latour4*, Ilene C. Weitz, MD5, Azalea Candelaria6*, Aliza Fink, D.Sc.7*, Alice Houk, MS6*, Elizabeth W Kottke, MPH, CPH, CHES7* and Brad A Wong6*

1NYU Cancer Institute, New York, NY
2King’s College Hospital-NHS Foundation Trust, NIHR/Wellcome King’s Clinical Research Facility, and King’s College London, London, United Kingdom
3Osaka University Graduate School of Medicine, Osaka, Japan
4BMT unit, Hôpital Saint-Louis,, Paris, France
5Division of Hematology, Keck School of Medicine of USC, Los Angeles, CA
6Aplastic Anemia & MDS International Foundation, Rockville, MD
7National Organization for Rare Diseases, Quincy, MA

Steven Fein, MD, MPH1, Dayne Alonso, PA-C1*, Gloria Campos1*, Adam K Lewkowitz, MD, MPHS2*, Layla N Van Doren, MD, MBA3, Michael Auerbach, MD4, Gina Peralta5* and Nicole Peralta5*

1Heme On Call, a telemedicine hematology medical practice, Miami, FL
2Department of Obstetrics and Gynecology, Brown University, Providence, RI
3Section of Hematology, Division of Medicine, Yale School of Medicine, New Haven, CT
4Auerbach Hematology and Oncology, Baltimore, MD
5GNP Research, Hollywood, FL

Gohul Gopi Jalajakumari, MD DNB1*, Manoj Unni, MD DM2*, Vidya Jha, MD3*, Bindhu Paul-Prasanth, PhD4*, Amal Nandu5*, Rema Ganapathy, MBBS, DNB6*, Monisha Harimadhavan, MD, DNB, DrNB7*, Gayathri Sajeevan, MD8*, Akhila M, BSc9*, Georg Gutjahr10*, Anandkrishnan N11*, Syamaprasad Vinayakumar, Pharm D12*, Ullas Mony, PhD13* and Neeraj Sidharthan, MD, MBBS, DM, DNB14

1Department of Clinical Haematology, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Cochin, Kerala, India
2Amrita institute of Medical sciences, Amrita Vishwa Vidyapeetham, Kochi, India
3Department of Cytogenetics, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham, ERNAKULAM, AL, India
4Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, kochi, India
5Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, India
6Department of Clinical Haematology, Amrita Institute of Medical Sciences , Amrita Viswa Vidyapeetam, Ernakulam, India
7Amrita Institute of Medical Sciences , Amrita Viswa Vidyapeetam, Kochi, India
8Amrita institute of medical science, Kochi, IND
9Department of Clinical Haematology , Transplant and Cellular Therapy, Amrita institute of Medical sciences, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India
10Department of Health Science Research, Amrita Institute of Medical Sciences, Kochi, India, Kochi, India
11Amrita school of Physical Sciences, Amita viswa vidyapeetam, Kochi, India
12Department of Clinical Haematology, Amrita institute of Medical sciences, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India
13Centre of Molecular Medicine and Diagnostics (COMManD), Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India
14Department of Clinical Haematology, Transplant and Cellular Therapy , Amrita Institute of Medical Sciences and Research Centre, Co-Director Amrita Amyloid Center, Amrita Vishwa Vidyapeetham, Kochi, India

Zulisa Saripuddin1*, Tze Yen Loo1*, Boey Yee Cheng1*, Aine Kyle, PhD2* and Ayse Levent, MSc3*

1Ipsos, Kuala Lumpur, Malaysia
2Ipsos, Maynooth, Ireland
3Ipsos, New York, NY

Adebimpe Adelaja, BS1*, Joseph R Stanek, MS2,3*, Meghan Pike, MD4*, Victoria E. Price, MBChB, MSc4* and Sarah H. O'Brien, MD, MSc2,5,6

1Center for Child Health Equity and Outcomes Research, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Canal Winchester, OH
2Division of Pediatric Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH
3Biostatistics Resource at Nationwide Children's Hospital, Columbus, OH
4Division of Pediatric Hematology Oncology, Department of Pediatrics, Dalhousie University, IWK Health Centre, Halifax, NS, Canada
5Department of Pediatrics, Ohio State University, Columbus, OH
6Center for Child Health Equity and Outcomes Research, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH

Bhavisha A. Patel, MD1, Emma M. Groarke, MD1, Ruba Shalhoub2*, Fernanda Rodrigues, PhD3*, Alice Fike, PA-C4*, Kaitlin Quinn, MD4*, Ivana Darden, RN1*, Shanni Liu, RN5*, Wendy Goodspeed, RN4*, Rui Miao6*, Colin O. Wu, PhD2*, Neal S. Young, MD1 and Peter C Grayson, MD4*

1Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
2Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
3Hematology Branch, National Heart Lung and Blood Institutes, National Institutes of Health, Bethesda
4NIAMS, National Institutes of Health, Bethesda, MD
5NIAMS, National Institutes of Health, Bethesda
6Office of Biostatistical Research, National Heart Lung and Blood Institute, Bethesda

Jonathan Tucci, MD, PhD1* and Allison P Wheeler, MD/MSCI2,3

1Vanderbilt University Medical Center, Nashville, TN
2University of Washington, Washington Center for Bleeding Disorders, Seattle, WA
3University of Washington, Seattle, WA

Zhengyi Cheng1,2*, Ziyue Zhang1,2*, Li Zhou, MD1,2*, Guojing Yuan1,2*, Mengyue Zhang1,2*, Haihao Shen1,2*, Xia Niu3* and Zhimin Zhai, MD1,2

1Department of Hematology, the Second Affiliated Hospital of Anhui Medical University, Hefei, China
2Anhui Medical University, Hefei, China
3School of Nursing, Anhui Medical University, Hefei, China

*signifies non-member of ASH